Unverified50% confidenceOpinionExact time
Interdisciplinary collaboration—including endocrinology, psychiatry, nutrition, and public health—is key to reducing the risk of eating disorders associated with GLP-1 drugs.
1
Sources
50%
Confidence
Long-term
Relevance
10/30/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedFor eating disorder patients with comorbid obesity, GLP-1 drugs may help control weight-related health risks.73% similarUnverifiedThe reason for weight rebound after discontinuing GLP-1 drugs is that they do not fundamentally alter the metabolic set point, and after stopping the drugs the body drives weight regain through increased hunger and reduced metabolic rate.66% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1115054API
curl https://kongchang.com/api/v1/knowledge/claims/1115054MCP
get_claim(id=1115054)